0000921895-22-000230.txt : 20220124
0000921895-22-000230.hdr.sgml : 20220124
20220124173035
ACCESSION NUMBER: 0000921895-22-000230
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220124
FILED AS OF DATE: 20220124
DATE AS OF CHANGE: 20220124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eberwein Jeffrey E.
CENTRAL INDEX KEY: 0001548312
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35947
FILM NUMBER: 22550481
MAIL ADDRESS:
STREET 1: 53 FOREST AVENUE, 1ST FLOOR
CITY: OLD GREENWICH
STATE: CT
ZIP: 06870
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STAR EQUITY HOLDINGS, INC.
CENTRAL INDEX KEY: 0000707388
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 330145723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 53 FOREST AVENUE
CITY: OLD GREENWICH
STATE: CT
ZIP: 06870
BUSINESS PHONE: 203-489-9501
MAIL ADDRESS:
STREET 1: 13100 GREGG STREET
STREET 2: SUITE A
CITY: POWAY
STATE: CA
ZIP: 92064
FORMER COMPANY:
FORMER CONFORMED NAME: DIGIRAD CORP
DATE OF NAME CHANGE: 19821006
4
1
form409271ebe_01242022.xml
OWNERSHIP DOCUMENT
X0306
4
2022-01-24
0
0000707388
STAR EQUITY HOLDINGS, INC.
STRR
0001548312
Eberwein Jeffrey E.
C/O STAR EQUITY HOLDINGS, INC.
53 FOREST AVENUE SUITE 101
OLD GREENWICH
CT
06870
1
1
1
0
Executive Chairman
Common Stock
2022-01-24
4
P
0
1075000
1.49
A
1923290
D
10% Series A Cumulative Perpetual Preferred Stock
1289978
D
Warrant
1.50
2022-01-24
4
P
0
1075000
0.01
A
2022-01-24
2027-01-24
Common Stock
1075000
1075000
D
The Reporting Person purchased the shares of common stock and the warrants reported on this Form 4 directly from the underwriter in an underwritten public offering conducted by the Issuer that closed on January 24, 2022. Each share of common stock was sold together with one warrant to purchase one share of common stock at a price of $1.50 per share and warrant, of which the price per share for common stock was $1.49 and the price per warrant was $0.01.
/s/ Jeffrey E. Eberwein
2022-01-24